APP and Alzheimer disease: Consistent with this idea, we found that CYFIP2 protein expression is reduced in an APP transgenic mouse line, the Tg2576 mouse, which models early Alzheimer’s disease (Hsiaoet al., 1996;Stewartet al., 2011).